Significance of serum tumor markers in monitoring advanced breast cancer patients treated with systemic therapy: A prospective study

Author:

Kurebayashi Junichi,Nishimura Reiki,Tanaka Katsuhiro,Kohno Norio,Kurosumi Masafumi,Moriya Takuya,Ogawa Yoshinari,Taguchi Tetsuya

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference11 articles.

1. Bast RCJr, Ravdin P, Hayes DF,et al: American Society of Clinical Oncology Tumor Markers Expert Panel: 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.J Clin Oncol 19:1865–1878, 2001.

2. Kurebayashi J, Yamamoto Y, Tanaka K,et al: Current status of tumor markers of breast cancer in Japan: a questionanaire survey to the board members of the Japanese Breast Cancer Society.Jpn J Breast Cancer 17:165–169, 2002 (in Japanese with English Abstract).

3. Kurebayashi J, Yamamoto Y, Tanaka K,et al: Significance of serum carcinoembryonic antigen and CA 15- 3 in monitoring advanced breast cancer patients treated with systemic therapy: a large-scale retrospective study.Breast Cancer 10:38–44, 2003.

4. Hayward JL, Carbone PP, Heusen JC,et al: Assessment of response to therapy in advanced breast cancer.BrJ Cancer 35:292–298, 1977.

5. Tondini C, Hayes DF, Gelman R,et al: Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.Cancer Res 48:4107–4112, 1988.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3